Scientific articles 17 Dec 2025 Kronopolitides A–F, a family of 36-membered polyol macrolides with antiparasitic activity against Chagas disease Journal of Natural Products
In the media 15 Dec 2025 The biggest mosquito-borne disease in the world has a cure. There’s just one problem Vox
News 4 Dec 2025 Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi
In the media 2 Dec 2025 “Como si me comiera desde dentro”: la enfermedad que ataca los huesos en el norte de Kenia EFE
Scientific articles 2 Dec 2025 The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities Parasites & Vectors
Press releases 27 Nov 2025 International seminar explores the development of treatments for dengue for populations not covered by vaccines
News 26 Nov 2025 DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment
Scientific articles 25 Nov 2025 Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing Clinical Pharmacology & Therapeutics
Videos 24 Nov 2025 Interview with Dr Pauline Williams, new DNDi Scientific Advisory Committee (SAC) Chair
Scientific articles 20 Nov 2025 Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants British Journal of Clinical Pharmacology
Press releases 8 Jun 2022 New WHO treatment guidelines offer hope for people co-infected with visceral leishmaniasis and HIV
Press releases 1 Jun 2022 Thai partners unite with DNDi to improve access to treatments and diagnostics for people with hepatitis C in Thailand
Press releases 18 May 2022 Consortium formed to discover antivirals for COVID-19 receives NIH funding to develop globally accessible treatments for pandemics
Press releases 29 Apr 2022 Ministry of Health, Malaysia and Drugs for Neglected Diseases initiative combine forces to lead the battle against dengue
Press releases 20 Apr 2022 DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue
Press releases 8 Apr 2022 Government of the Principality of Monaco supports DNDi to increase access to improved treatment for children with HIV
Press releases 15 Mar 2022 Pfizer blocking research to generate evidence on optimal use of novel antiviral for COVID-19 patients in low- and middle-income countries
Press releases 28 Feb 2022 ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients
Press releases 25 Feb 2022 Expert consortium begins study in South Africa to develop an optimized treatment for cryptococcal meningitis
Press releases 10 Feb 2022 ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment
Press releases 13 Jan 2022 Germany’s Federal Ministry of Education and Research (BMBF) grants additional funding to six PDPs fighting poverty-related and neglected tropical diseases
Press releases 4 Nov 2021 GHIT Fund expands support for DNDi Chagas disease drug discovery programmes
Press releases 27 Sep 2021 COVID Moonshot funded by COVID-19 Therapeutics Accelerator to rapidly develop a safe, globally accessible and affordable antiviral pill
Press releases 30 Aug 2021 Chagas: new study puts researchers closer to shortening the length of treatment
Press releases 5 Aug 2021 New DNDi report: International community must not repeat mistakes that have led to COVID-19 vaccine inequality by restricting access to new treatments for COVID-19
